Table I.
Characteristics of study participants treated on Southwest Oncology Group Protocol S0433.
| Characteristic | N=84 Eligible | |
|---|---|---|
| Age, median (range) | years | 64 (29–85) |
| Gender, n (%) | Female | 45 (54%) |
| Race, n (%) | White | 78 (93%) |
| Ethnicity, n (%) | Hispanic | 3 (4%) |
| IPI Risk level, n (%) | Low | 20 (24%) |
| Low-Intermediate | 27 (32%) | |
| High-Intermediate | 27 (32%) | |
| High | 10 (12%) | |
| Immunohistochemistry, n (%)* | BCL2+ | 57 (86%) |
| MYC+ | 15 (23%) | |
| BCL2+MYC+ | 13 (20%) |
*
successfully completed on N=66 subjects
IPI, International Prognostic Index